KGI Faculty Member Assumes New Role at Coherus BioSciences
KGI faculty is known for their impressive science credentials combined with extensive experience in the corporate sector. KGI adjunct professor Vince Anicetti is no exception, recently having been appointed as senior vice president, global quality at Coherus BioSciences. Headquartered in the San Francisco Bay area, Coherus is focused on delivering high-quality biosimilar therapeutics that will expand patient access to life-changing medications. The company is founded by a group of biotech pioneers who helped build America's first-generation biotherapeutics industry.
"Vince's breadth and depth of experience will be critical to delivering to patients high-quality biosimilars with robust consistency," said Denny Lanfear, president and CEO of Coherus. "We are thrilled to welcome Vince to the Coherus team as we advance global development and commercialization strategies across our portfolio."
Prior to joining Coherus, Anicetti served as the executive director of quality for Boehringer-Ingelheim's California facility. Previously, he spent 30 years with Genentech and held senior leadership roles in quality, regulatory affairs and project portfolio management, including vice president of biologics quality for Genentech and Roche Biologics manufacturing sites around the world. At KGI, he teaches classes in biopharmaceutical quality and CMC regulatory affairs. A past chair of the Parenteral Drug Association (PDA), Anicetti also serves on the San Francisco State University Foundation Board. He holds B.A. and M.S. degrees in biological sciences from San Francisco State University.